Cite
MLA Citation
Paul Emery et al.. “Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study.” Annals of the rheumatic diseases, vol. 79, no. 8, 2020, pp. 1023–1030. http://access.bl.uk/ark:/81055/vdc_100127567951.0x000064